Enveric Biosciences (ENVB) News Today $0.32 0.00 (-1.04%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Enveric's Pre-clinical Study Of EB-003 Shows Bioavailability, Brain Penetration In Animal StudiesNovember 25, 2024 | markets.businessinsider.comEnveric Biosciences Reports Third Quarter 2024 Financial and Corporate ResultsNovember 14, 2024 | businesswire.comEnveric in out-licensing deal with MycoMedica Life for EB-002November 13, 2024 | markets.businessinsider.comEnveric Biosciences Out-Licenses Key Program To MycoMedica In $62M DealNovember 13, 2024 | benzinga.comEnveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002November 13, 2024 | finance.yahoo.comEnveric Biosciences Expands Mental Health Patent Portfolio With 5 New AdditionsNovember 5, 2024 | msn.comEnveric Biosciences Announces Broad Range of Patent IssuancesNovember 4, 2024 | businesswire.comEnveric Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | finance.yahoo.comEnveric Biosciences, Inc. (ENVB)August 26, 2024 | nz.finance.yahoo.comEnveric secures patent for radiation dermatitis topical productAugust 15, 2024 | uk.investing.comEnveric Biosciences Reports Second Quarter 2024 Financial and Corporate ResultsAugust 13, 2024 | finance.yahoo.comNon-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed OrallyJuly 25, 2024 | msn.comEnveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed OrallyJuly 25, 2024 | finance.yahoo.comDiamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB)June 28, 2024 | globenewswire.comEnveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development CandidateJune 25, 2024 | businesswire.comEnveric Biosciences to Participate in BIO International Convention 2024May 30, 2024 | businesswire.com'Psychedelics-Inspired' Meds For Depression, Anxiety, Addiction Producer Trims Q1 Net Loss YoY, Increases Cash On HandMay 16, 2024 | benzinga.comEnveric Biosciences GAAP EPS of -$0.61May 15, 2024 | msn.comEnveric Biosciences Reports First Quarter 2024 Financial and Corporate ResultsMay 15, 2024 | businesswire.comMicrodosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug CandidateMay 14, 2024 | msn.comEnveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health DisordersMay 14, 2024 | businesswire.comCannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented MethodsMay 8, 2024 | msn.comEnveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using CannabinoidsMay 8, 2024 | businesswire.comEnveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future GrowthMarch 27, 2024 | benzinga.comEnveric Biosciences Inc (ENVB)March 21, 2024 | uk.investing.comWhy Is Anxiety/Addiction-Focused Enveric Biosciences Stock Trading Higher Tuesday?March 19, 2024 | msn.comEnveric gains on out-licensing deal of new chemical entities for joint disease treatmentsMarch 19, 2024 | msn.comEnveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint DiseaseMarch 19, 2024 | finance.yahoo.comEnveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term SheetsMarch 12, 2024 | finance.yahoo.comPsyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And MoreMarch 4, 2024 | msn.comWhy Is Enveric Biosciences (ENVB) Stock Up 120% Today?February 29, 2024 | investorplace.comEnveric Signs Term Sheets To Pursue Out-licensing Of Three Classes Of CompoundsFebruary 29, 2024 | markets.businessinsider.comEnveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of CompoundsFebruary 29, 2024 | businesswire.comCORRECTION – Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB)February 26, 2024 | finance.yahoo.comEnveric Biosciences To Sell Cannabinoid-Related Cancer Intellectual Property; Stock Up In Pre-MarketFebruary 23, 2024 | markets.businessinsider.comEnveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual PropertyFebruary 23, 2024 | businesswire.comEnveric Biosciences Deepens Its Mental Health-Focused Pipeline With Library of Preclinical CompoundsFebruary 21, 2024 | msn.comEnveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health DisordersFebruary 21, 2024 | finance.yahoo.comEnveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health DisordersFebruary 21, 2024 | businesswire.comPsychedelic stocks gain after FDA priority review for MDMA therapyFebruary 12, 2024 | msn.comEnveric Biosciences Granted Extension to Avoid Nasdaq DelistingFebruary 10, 2024 | msn.comEnveric Biosciences Updates Key Data Underpinning Selection of EB-003 as Lead Drug Candidate from EVM301 SeriesJanuary 3, 2024 | finance.yahoo.comEnveric stock jumps 13% on pipeline updateDecember 28, 2023 | msn.comEnveric Biosciences Shares Rise 7% After Selecting Lead Drug CandidateDecember 28, 2023 | marketwatch.comEnveric Biosciences Selects EB-003 as Lead Drug Candidate from EVM301 SeriesDecember 28, 2023 | finance.yahoo.comEnveric Biosciences Reports Year End Progress for Preclinical Development of Lead Prodrug Candidate EB-373December 27, 2023 | finance.yahoo.comBears are Losing Control Over Enveric Biosciences, Inc. (ENVB), Here's Why It's a 'Buy' NowDecember 20, 2023 | finance.yahoo.com5 Biotech stocks tapping into unmet mental health treatment needs (ENVB)Here are five biotech companies currently working on drug candidates that tap into this soaring need for life-saving mental health treatments.December 20, 2023 | marketbeat.comEnveric Biosciences to Participate in Biotech Showcase 2024 During "J.P. Morgan Week 2024"December 20, 2023 | finance.yahoo.comEnveric Biosciences Selects Development Candidates from EVM301 Series Based on Potential to Minimize or Eliminate the Hallucinogenic Effect of Psychedelic-Derived CompoundsDecember 5, 2023 | finance.yahoo.com Get Enveric Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ENVB and its competitors with MarketBeat's FREE daily newsletter. Email Address 70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << ENVB Media Mentions By Week ENVB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENVB News Sentiment▼0.000.60▲Average Medical News Sentiment ENVB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENVB Articles This Week▼00▲ENVB Articles Average Week Get Enveric Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ENVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ACXP News CARA News HCWB News TXMD News MRNS News SLGL News CING News IPA News NRSN News IMNN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ENVB) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enveric Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
